Skip to main content
Clinical Trials/NL-OMON45755
NL-OMON45755
Completed
Not Applicable

Optical Coherence Tomography to visualize neuropathology in Alzheimer's disease - OCT in AD

Vrije Universiteit Medisch Centrum0 sites120 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Alzheimer's disease and dementia
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
120
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Study cases: patients with AD fulfilling the clinical criteria, a MMSE\-score of at least 17/30 and proven to be amyloid positive by either decreased CSF A\* or a positive amyloid PET scan.
  • \- Controls: patients with subjective memory complaints visiting the Alzheimer center, without diagnosis of AD or other neurodegenerative disease, proven to be amyloid negative by either normal CSF A\* or negative amyloid PET scan.

Exclusion Criteria

  • \- Subjects with neuro\-opthalmological conditions which may interfere with the OCT data
  • \- Subjects with progressive dementia, with an MMSE below 17/30 and/or incapacitated and not capable to give informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials